Pressure Biosciences, Inc. (PBIO) Reports Increase of Sales, Revenue, and Cash on Hand
Pressure Biosciences, Inc. (NASDAQ: PBIO) recently reported the sale of four of its Barocycler NEP3229 PCT Sample Preparation Systems. Compare that to the sale of only one system in the second quarter of last year, and you’ve got a company on the move. The company also posted $65,772 in grant revenue for the quarter ended June 30, 2007; last year it reported none. Additionally, Pressure Biosciences posted $202,127 for the second quarter of 2007, as compared to $28,783 in the same period of 2006. Cash on hand as of June 30, 2007, was about $6.8 million, up from $5.3 million…